Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Targets and Therapy [Lung Cancer]"'
Autor:
Jared Deck, Marissa Hartley, Mohammad Akhter, Dongliang Wang, Jeffrey A Bogart, Michael D Mix
Publikováno v:
Lung Cancer: Targets and Therapy. 14:47-55
Jared Deck,1 Marissa Hartley,1 Mohammad Akhter,1 Dongliang Wang,2 Jeffrey A Bogart,1 Michael D Mix1 1Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY, USA; 2Department of Public Health and Preventive Medicine, SUNY Upst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70c5e9dc548a633522654cfbd2b061ff
https://doi.org/10.2147/lctt.s386344
https://doi.org/10.2147/lctt.s386344
Publikováno v:
Lung Cancer: Targets and Therapy. 14:31-39
Danielle Brazel,1 Jennifer Kim,1 Sai-Hong Ignatius Ou1,2 1University of California Irvine School of Medicine, Department of Internal Medicine, Division of Hematology-Oncology, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf9c8e85e59ce651fb5cd65b215f5c11
https://doi.org/10.2147/lctt.s403614
https://doi.org/10.2147/lctt.s403614
Autor:
Lee,Alexandria TM, Ou,Saihong Ignatius
Publikováno v:
Lung Cancer: Targets and Therapy.
Alexandria TM Lee,1 Saihong Ignatius Ou1,2 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USACorrespondence: Saihong Ignatius Ou, University of Calif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dovemedicalp::1a1bf32b499244b8f6f83b30a23d942c
https://www.dovepress.com/alesia-5-year-update-alectinib-at-600-mg-twice-daily-gives-lorlatinib--peer-reviewed-fulltext-article-LCTT
https://www.dovepress.com/alesia-5-year-update-alectinib-at-600-mg-twice-daily-gives-lorlatinib--peer-reviewed-fulltext-article-LCTT
Autor:
Brazel,Danielle, Ou,Saihong Ignatius
Publikováno v:
Lung Cancer: Targets and Therapy.
Danielle Brazel,1 Saihong Ignatius Ou1,2 1University of California Irvine School of Medicine, Department of Medicine, Orange, CA, 92868, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, 92868, USACorrespondence: Saihong Ignatius Ou, Univers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dovemedicalp::4c81a22a42cc22b888d160c2bdcced3e
https://www.dovepress.com/the-additional-exclusions-of-ros1-fusions-in-addition-to-egfr-mutation-peer-reviewed-fulltext-article-LCTT
https://www.dovepress.com/the-additional-exclusions-of-ros1-fusions-in-addition-to-egfr-mutation-peer-reviewed-fulltext-article-LCTT
Autor:
Lee,Alexandria TM, Ou,Saihong Ignatius
Publikováno v:
Lung Cancer: Targets and Therapy.
Alexandria TM Lee,1 Saihong Ignatius Ou1,2 1University of California Irvine School of Medicine, Department of Medicine, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USACorrespondence: Saihong Ignatius Ou, University of Calif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dovemedicalp::9cfcec30d2d75438cbab0b0572411d37
https://www.dovepress.com/from-ascend-5-to-alur-to-alta-3-an-anti-climactic-end-to-the-era-of-ra-peer-reviewed-fulltext-article-LCTT
https://www.dovepress.com/from-ascend-5-to-alur-to-alta-3-an-anti-climactic-end-to-the-era-of-ra-peer-reviewed-fulltext-article-LCTT
Autor:
Alexandria TM Lee, Misako Nagasaka
Publikováno v:
Lung Cancer: Targets and Therapy.
Alexandria TM Lee,1 Misako Nagasaka1,2 1University of California Irvine School of Medicine, Department of Medicine, Orange, CA, 92868, USA; 2St. Marianna University School of Medicine, Department of Medicine, Kawasaki, JapanCorrespondence: Misako Nag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c782a1aac6bb2de296145f325f764e24
https://www.dovepress.com/checkmate-722-the-rise-and-fall-of-nivolumab-with-chemotherapy-in-tki--peer-reviewed-fulltext-article-LCTT
https://www.dovepress.com/checkmate-722-the-rise-and-fall-of-nivolumab-with-chemotherapy-in-tki--peer-reviewed-fulltext-article-LCTT
Publikováno v:
Lung Cancer: Targets and Therapy.
Shannon S Zhang,1 Alexandria Lee,1 Misako Nagasaka1,2 1University of California Irvine School of Medicine, Orange, CA, USA; 2St. Marianna University School of Medicine, Kawasaki, JapanCorrespondence: Misako Nagasaka, University of California Irvine S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1020c0b9aaf72adec411406e770b064a
https://www.dovepress.com/codebreak-200-sotorasib-has-not-broken-the-krasg12c-enigma-code-peer-reviewed-fulltext-article-LCTT
https://www.dovepress.com/codebreak-200-sotorasib-has-not-broken-the-krasg12c-enigma-code-peer-reviewed-fulltext-article-LCTT
Autor:
Nigro,Maria Concetta, Marchese,Paola Valeria, Deiana,Chiara, Casadio,Chiara, Galvani,Linda, Di Federico,Alessandro, De Giglio,Andrea
Publikováno v:
Lung Cancer: Targets and Therapy.
Maria Concetta Nigro,1 Paola Valeria Marchese,1 Chiara Deiana,1 Chiara Casadio,1 Linda Galvani,1 Alessandro Di Federico,1 Andrea De Giglio1,2 1Department of Experimental, Diagnostic and Specialty Medicine, S.Orsola-Malpighi University Hospital, Unive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dovemedicalp::e0c2db434ed102e2f9df8eb23d85284b
https://www.dovepress.com/clinical-utility-and-application-of-liquid-biopsy-genotyping-in-lung-c-peer-reviewed-fulltext-article-LCTT
https://www.dovepress.com/clinical-utility-and-application-of-liquid-biopsy-genotyping-in-lung-c-peer-reviewed-fulltext-article-LCTT
Publikováno v:
Lung Cancer: Targets and Therapy.
Danielle Brazel,1 Sai-Hong Ignatius Ou,1,2 Misako Nagasaka1â 3 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USA; 3St. Marianna University Scho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dovemedicalp::a4c5f861591fb046507d75859292d1a3
https://www.dovepress.com/tiragolumab-anti-tigit-in-sclc-skyscraper-02-a-towering-inferno-peer-reviewed-fulltext-article-LCTT
https://www.dovepress.com/tiragolumab-anti-tigit-in-sclc-skyscraper-02-a-towering-inferno-peer-reviewed-fulltext-article-LCTT
Publikováno v:
Lung Cancer: Targets and Therapy.
Danielle Brazel,1 Zhaohui Arter,1 Misako Nagasaka1â 3 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USA; 3St. Marianna University School of Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dovemedicalp::3d7194fa03294eaa4cd662a6d8c982dc
https://www.dovepress.com/a-long-overdue-targeted-treatment-for-kras-mutations-in-nsclc-spotligh-peer-reviewed-fulltext-article-LCTT
https://www.dovepress.com/a-long-overdue-targeted-treatment-for-kras-mutations-in-nsclc-spotligh-peer-reviewed-fulltext-article-LCTT